The Traumatic Brain Injury Therapeutics Market is estimated to be valued at US$ 3.46 Billion In 2022 and is expected to exhibit a CAGR of 6.20% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights. Market Overview: Traumatic Brain Injury Therapeutics Market refers to the pharmaceutical products and therapies used in the treatment of traumatic...
The traumatic brain injury therapeutics market comprises drugs and devices meant for the treatment of traumatic brain injuries. Traumatic brain injuries, also known as TBIs, occur due to a bump, blow or jolt to the head that disrupts normal brain functioning. Common causes of TBIs include falls, vehicle accidents, sports-related injuries and assaults. Therapeutics for TBIs include medications...